Nationwide Recall of Ibuprofen and Oxcarbazepine Tablets

American Health Packaging (AHP) recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation that may contain individual blistered doses labeled as Oxcarbazepine Tablets, 300 mg, lot #142544. In addition, AHP has recalled Oxcarbazepine Tablets, 300 mg, lot #142544, Expiration Date, 02/2016. These hospital unit dose products were distributed nationwide beginning June 20, 2014. Mislabeled inner unit dose blister packaging could result in patients receiving ibuprofen and missing their scheduled dose of Oxcarbazepine.


Ibuprofen 600 mg tablets are indicated for the relief of mild to moderate pain; for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis; and treatment of primary dysmenorrhea. Inadvertent consumption of ibuprofen may cause adverse reactions in a number of patients in which use of ibuprofen is contraindicated.


Oxcarbazepine is used for treating certain types of seizures in patients with epilepsy. Failure to receive the proper dose of Oxcarbazepine could increase the chances of having a seizure.


At this time AHP has received one customer complaint which resulted in the investigation and recall of these drug products.


See the Recall


See also Medical Law Perspectives, August 2014 Report: Malpractice in the Diagnosis and Treatment of Epilepsy and Seizure Disorders (to be published August 6, 2014)


See also Medical Law Perspectives, May 2013 Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication